Sartorius Stedim Biotech Reports Q3 EPS of €2.84 on €2.29 Billion Revenue

Key Facts

1Sartorius Stedim Biotech reported Non-GAAP EPS of €2.84.

2The company's revenue reached €2.29 billion for the period.

Sartorius Stedim Biotech reported Non-GAAP EPS of €2.84 for the third quarter of 2026. Seeking Alpha reported that the company's revenue reached €2.29 billion for the period, as the firm confirmed its financial guidance for the full fiscal year.

SRTOY closed at $24.20 on October 21, 2026, while the parent company's stock SOAGY closed at $58.60 on the same date. These results reflect the company's financial performance amid continued positive business momentum in the biotechnology sector.